Skip to main content
Fig. 7 | Journal of Nanobiotechnology

Fig. 7

From: Biodegradable and biocompatible subcutaneous implants consisted of pH-sensitive mebendazole-loaded/folic acid-targeted chitosan nanoparticles for murine triple-negative breast cancer treatment

Fig. 7

Mouse body response to the subcutaneously implanted CS-FA-MBZ at 3rd day after implantation according to histopathology analysis. a A close-up view of a CS-FA-MBZ implant 3rd day after implantation and histopathological evaluation of b the implant-surrounding membrane, c tissues far away from the implantation site, and d tissues at the bed of the implantation site. The two head arrows, asterisk, and one-head arrows indicate derma, the implant’s surrounding membrane, and infiltrating immune cells, respectively

Back to article page